Target Oncology is an emerging biotech company developing oncology supportive care products in areas of unmet and underserved, medical need.
Medical Device Products - Clear Benefit Technology
Compelling Business Model – Novel, First-to-Market
Pipeline FDA 510(K) application ready
Oncology Sales Team in Place (50+ pp)
Robust, established provider relationships
Experienced management
~ $450+ M projected revenues by year 5